Restless Legs Syndrome: More Than Just an Annoyance
If you’ve never experienced restless legs syndrome, it’s genuinely hard to understand. “My legs feel restless” sounds trivial — like a minor discomfort, easily ignored. But talk to someone with moderate-to-severe RLS and you’ll hear descriptions that are anything but trivial: a crawling sensation deep in the calves, an irresistible urge to move that intensifies the moment you try to rest, nights spent pacing the house at 2 AM because lying still has become unbearable.
RLS is one of the most common sleep disorders we see in clinical practice, affecting somewhere between 5-10% of the adult population according to data from the National Institutes of Health. Yet it remains underdiagnosed, often dismissed, and frequently treated incorrectly.
What RLS Actually Is
Restless legs syndrome is a neurological sensorimotor disorder. The hallmark is an unpleasant sensation in the legs (and occasionally arms) accompanied by an overwhelming urge to move them. Four diagnostic criteria define it:
- An urge to move the legs, usually accompanied by uncomfortable sensations
- Symptoms begin or worsen during rest or inactivity
- Symptoms are partially or totally relieved by movement
- Symptoms are worse in the evening or at night
That circadian pattern is important and often overlooked. RLS isn’t just about restless legs — it’s about restless legs that specifically torture you when you’re trying to sleep. The timing is what makes it a sleep disorder, not just a neurological curiosity.
The Iron Connection
If there’s one thing most people don’t know about RLS, it’s the role of iron. Brain iron levels are central to RLS pathophysiology. Specifically, iron is a cofactor for tyrosine hydroxylase, the enzyme that produces dopamine. When brain iron is low, dopamine signalling goes haywire, and RLS symptoms emerge.
This is why the first thing any competent sleep physician does when evaluating RLS is check serum ferritin. Not just haemoglobin or iron levels — ferritin, because it better reflects iron stores. A ferritin below 75 ng/mL in someone with RLS symptoms should prompt iron supplementation, and many patients see significant improvement from this alone.
The catch: ferritin levels that would be considered “normal” in a general medical context (above 12-15 ng/mL) are often inadequate for RLS. This is why many RLS patients are told their iron levels are “fine” by their GP when they’re actually well below the threshold where RLS symptoms improve. It’s a frustrating gap between general medicine and sleep medicine knowledge.
The Dopamine Agonist Problem
For years, dopamine agonists like pramipexole and ropinirole were the go-to medications for RLS. They work — often dramatically, at first. Patients who’d been suffering for years would report near-complete symptom relief within days.
Then came augmentation.
Augmentation means RLS symptoms begin occurring earlier in the day, spreading to new body parts, and becoming more intense than before treatment started. It happens in 20-50% of patients on long-term dopamine agonists. You’ve taken a patient whose symptoms were confined to nighttime and transformed them into someone whose legs bother them by mid-afternoon. And increasing the dose only accelerates the problem.
The International Restless Legs Syndrome Study Group now recommends using dopamine agonists at the lowest possible dose and considering them as second-line therapy rather than first-line. But many patients were started on these medications years ago and are now dealing with augmentation.
What Works Better
Iron supplementation remains the first step. Oral iron (ferrous sulfate or ferrous bisglycinate, taken on an empty stomach with vitamin C) is the starting point. If oral iron doesn’t raise ferritin adequately, or if symptoms are severe, intravenous iron infusion is increasingly used and can provide dramatic improvement.
Alpha-2-delta ligands — gabapentin and pregabalin — have moved to first-line pharmacological treatment. They don’t carry the augmentation risk of dopamine agonists and address both the sensory discomfort and the sleep disruption. They’re not without side effects (drowsiness, dizziness, weight gain), but the benefit-risk profile is generally better than dopamine agonists for long-term use.
Non-pharmacological approaches deserve more attention than they get. Regular moderate exercise improves RLS symptoms in multiple studies, though intense evening exercise can worsen them. Reducing caffeine and alcohol helps some patients. Leg massage, warm baths, and compression devices have limited but real evidence supporting them.
When It’s Not “Just” RLS
RLS commonly coexists with periodic limb movement disorder (PLMD), where repetitive leg jerks during sleep fragment rest and cause daytime fatigue. About 80% of RLS patients also have PLMD.
RLS is also more common in pregnancy (up to 25% of women in the third trimester), chronic kidney disease, and with certain medications — antihistamines, most antidepressants, and antipsychotics. Identifying these contributing factors is just as important as prescribing medication.
The Takeaway
RLS deserves better than dismissal. It’s a neurological condition with identifiable pathophysiology, effective treatments, and real consequences for sleep quality and quality of life when left unmanaged. If your legs won’t let you rest, that’s worth investigating properly — not just with a blood test and a shrug, but with someone who understands the condition’s nuances.
The crawling won’t stop on its own. But with the right approach, it doesn’t have to run your nights.